Wells Fargo Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $19
UBS Maintains Neutral on Healthpeak Properties, Lowers Price Target to $20
Barclays Maintains Equal-Weight on Healthpeak Properties, Lowers Price Target to $21
Healthpeak Properties (DOC) Reaffirmed Its Dividend, Is It Still Below Fair Value?
Did Healthpeak’s (DOC) Steady 2026 Payout and Higher FFO Guidance Quietly Redefine Its Capital Priorities?
Healthpeak Properties (DOC) Stock Still Looks Cheap Following Its 31% Run
Healthpeak Properties: High Yield, Strong Balance Sheet, And Upside Potential
Healthpeak Properties Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and Webcast
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026
This Dividend Stock Pays You 12 Times Per Year. Here's What a $25,000 Investment Deposits Each Month.
How Investors May Respond To Healthpeak Properties (DOC) Upgrading Its 2026 Cash-Flow Guidance
Vital Signs Strong For This High-Yield Healthcare REIT
Healthpeak Properties (DOC) Lifts 2026 Guidance, Is The Stock Still A Bargain?
Is Healthpeak Properties Stock Underperforming the S&P 500?
Evercore ISI Group Maintains In-Line on Healthpeak Properties, Lowers Price Target to $22
Healthpeak (DOC) Turns Portfolio Sales Into Fatter 2026 Guidance
Healthpeak Properties: Buy Reaffirmed As Outpatient And Senior Portfolio Shows Proven Performance
Jefferies Assumes Healthpeak Properties at Hold, Lowers Price Target of $21
Healthpeak Properties Inc's Dividend Analysis
Why Is Healthpeak (DOC) Down 3.5% Since Last Earnings Report?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.